CanSino Biologics Inc. (HKG:6185)
Hong Kong · Delayed Price · Currency is HKD 25.82
+0.36 (1.41%)
May 29, 2026, 4:08 PM HKT
CanSino Biologics Market Cap
CanSino Biologics has a market cap or net worth of 11.18 billion as of May 29, 2026. Its market cap has decreased by -1.32% in one year.
Market Cap
11.18B
Enterprise Value
9.76B
Revenue
1.27B
Ranking
n/a
PE Ratio
n/a
Stock Price
25.82
Market Cap Chart
Since March 28, 2019, CanSino Biologics's market cap has increased from 7.57B to 11.18B, an increase of 47.63%. That is a compound annual growth rate of 5.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 11.18B | -11.51% |
| Dec 31, 2025 | 12.63B | 8.81% |
| Dec 31, 2024 | 11.61B | -7.23% |
| Dec 29, 2023 | 12.51B | -54.81% |
| Dec 30, 2022 | 27.69B | -58.12% |
| Dec 31, 2021 | 66.11B | -11.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 28, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fujian Haixi Pharmaceuticals | 18.28B |
| The United Laboratories International Holdings | 16.75B |
| Consun Pharmaceutical Group | 11.77B |
| Ab&B Bio-Tech CO., LTD. JS | 11.54B |
| Shandong Xinhua Pharmaceutical Company | 8.83B |
| Sihuan Pharmaceutical Holdings Group | 8.59B |
| Luye Pharma Group | 8.43B |
| CF PharmTech | 8.30B |